NCT03998592 - Clinical Trial to Assess Safety and Immunogenicity of a Synthetic Vaccine Against Streptococcus Pyogenes | Biotech Hunter

Timeline

Start Date

May 31, 2021

Primary Completion Date

March 31, 2022

Study Completion Date

October 31, 2023

Conditions

Rheumatic Fever

Interventions

BIOLOGICAL

Streptococcus pyogenes vaccine (50 µg)

Vaccine containing 50 µg of StreptInCor synthetic peptide and Aluminium Hydroxide as adjuvant

BIOLOGICAL

Streptococcus pyogenes vaccine (100 µg)

Vaccine containing 100 µg of StreptInCor synthetic peptide and Aluminium Hydroxide as adjuvant

BIOLOGICAL

Streptococcus pyogenes vaccine (200 µg)

Vaccine containing 200 µg of StreptInCor synthetic peptide and Aluminium Hydroxide as adjuvant

OTHER

Placebo

Placebo without active component